The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS clinical trials group 328.

Saved in:
Bibliographic Details
Title: The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS clinical trials group 328.
Authors: Mitsuyasu R (AUTHOR), Gelman R (AUTHOR), Cherng DW (AUTHOR), Landay A (AUTHOR), Fahey J (AUTHOR), Reichman R (AUTHOR), Erice A (AUTHOR), Bucy RP (AUTHOR), Kilby JM (AUTHOR), Lederman MM (AUTHOR), Hamilton CD (AUTHOR), Lertora J (AUTHOR), White BL (AUTHOR), Tebas P (AUTHOR), Duliege AM (AUTHOR), Pollard RB (AUTHOR)
Source: Archives of Internal Medicine. 3/26/2007, Vol. 167 Issue 6, p597-605. 9p.
Database: Academic Search Ultimate
Description
ISSN:00039926
DOI:10.1001/archinte.167.6.597